Given the evolution and the gravity of the situation regarding COVID-19, the fifth edition of Viva Technology will not take place June 11-13. Alternative solutions are being studied, in concertation with the main partners of the event, and will be announced soon.
The containment measures decreed by the national authorities in France now make it impossible to prepare and organize the event on the dates originally planned. Especially since, as announced, the containment is likely to be extended as has been the case in China and Italy. VivaTech's priority is to guarantee the health and safety of visitors, partners and staff and to show solidarity and responsibility in the face of this health crisis.
All the Startup applicants to the VivaTech Challenges will get noticed by each Challenge Partner regarding the next steps of the selection. This decision could possibly impact the results announcement date.
Our thoughts are with all those affected by this crisis.
WHAT IS VIVATECH?
VivaTech is the world’s rendezvous for startups and leaders to celebrate innovation!
This international event is a gathering of the world’s brightest minds, talents, and products and is a celebration of today’s innovations and tomorrow’s possibilities for everyone who believes in the power of technology to transform business and society! VivaTech is dedicated to the growth of startups, hosting more than 13 000 of them and enable them to present their innovation on the market. Learn more about all Challenges here and click here to check out our website
Accelerate innovation in Africa for better care
Anyone should be able to own their personal health data safely, to easily recall their health history and facilitate the right dialogue and decision with doctors. The proposed solution should contain major health event data (vaccinations, lab results, disease history, prescriptions, and guidance & tips).
In some countries, logistics data at the point of care are not digitalized, which leads to:
- Unoptimized supply chain;
- No batch traceability, fake medicines;
- Heavy paperwork;
- The solution should ensure appropriate drug delivery to patients.
Access to new therapeutic solutions remains a major challenge for a large part of population in Africa.
The proposed solution should bear upon innovative financing options and must be able to measure the impact. Startups already working with banks and insurance are welcome.
Maternal and child mortality remains a major concern in sub-Saharan Africa with 2/3 of worldwide maternal deaths. The foundation, with its local and global partners, aims at identifying novel solutions by tackling social determinants of maternal health and meeting women’s needs First pilot will be in Senegal.
- A corner to demonstrate your solution to the attendees in the Lab
- Develop your network with key stakeholders and investors
- 4 tickets / 3 days at VivaTech
- Some support for traveling costs to Paris
- Opportunity to attend a pitch preparation workshop the day before VivaTech
- Pitch in front of a jury composed of Sanofi top executives and key external stakeholders
Engage deep discussion with expert functions and Sanofi in Africa General Managers to assess feasibility of future collaboration in Africa (e.g. potential pilot, potential scale up in another African country...)
Coaching / Mentoring & potential acceleration, with involvement of Sanofi Africa Leadership team
Opportunity for an access to Sanofi internal expertise to support your business and your international growth strategy